Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 168,775 Less Arrow 161,242 More Arrow 316,416
Earnings before taxes 5,237 More Arrow 10,072 Less Arrow 7,152
Total assets 134,954 Less Arrow 115,942 More Arrow 203,148
Current assets 122,282 Less Arrow 103,931 Less Arrow 83,318
Current liabilities 66,278 Less Arrow 52,719 Less Arrow 52,313
Equity capital 48,075 Less Arrow 43,064 More Arrow 107,311
- share capital 770 Less Arrow 744 More Arrow 748
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 35.6% More Arrow 37.1% More Arrow 52.8%
Turnover per employee
Profit as a percentage of turnover 3.1% More Arrow 6.2% Less Arrow 2.3%
Return on assets (ROA)
Current ratio 184.5% More Arrow 197.1% Less Arrow 159.3%
Return on equity (ROE) 10.9% More Arrow 23.4% Less Arrow 6.7%
Change turnover 2,017 Less Arrow -153,554 More Arrow 168,818
Change turnover % 1% Less Arrow -49% More Arrow 114%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.